Clinical evaluation of NM441 in respiratory infections

Japanese Journal of Chemotherapy

Volumn 44, Issue SUPPL. 1, 1996, Pages 639-641

  Kobashi, Yoshihiro ^a   Matsushima, Toshiharu ^a   Tomizawa, Sadao ^a   Tano, Yoshihiko ^a   Tanabe, Jun ^a   Kimura, Makoto ^a   Samukawa, Masanobu ^a   Adachi, Michifumi ^a   Nakamura, Junichi ^a   Yano, Tatsutoshi ^a   Yoneyama, Hirohide ^a   Taniguchi, Makoto ^a  

^a KAWASAKI MEDICAL SCHOOL   (Japan)

Author keywords

clinical efficacy; NM441; respiratory infection

Indexed keywords

PRULIFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DOSE RESPONSE; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; MALE; ORAL DRUG ADMINISTRATION; PSEUDOMONAS AERUGINOSA; RESPIRATORY TRACT INFECTION; STAPHYLOCOCCUS AUREUS;

EID: 15844404356     PISSN: 13407007     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (6)

1. Segawa J, Kitano M, Kazuno K, Matsuoka M, Shirahase I, Ozaki M, Matsuda M, Tomii Y, Kise M : Studies on pyridonecarboxylic acids. 1. Synthesis and antibacterial evaluation of 7-substituted-6-halo-4-oxo-4H-[1, 3]thiazeto[3, 2-a]quinoline-3-carboxylic acids. J Med Chem 35: 4727-4738, 1992
2. Ozaki M, et al : In vitro antibacterial activity of a new quinolone, NM394. Antimicrob Agents Chemother 35 : 2490-2495, 1991